Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Minglip Bos 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Siskan Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Minglip Bos 2mg/500mg/0.2mg Tablet

Diabex Trio 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination drug treats type 2 diabetes in adults by regulating blood glucose. Diabex Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan that includes a balanced diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect of Diabex Trio. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Regular meals and carrying a fast-acting glucose source (e.g., sugary snacks or juice) are preventative measures. Alcohol consumption increases hypoglycemia risk and should be minimized. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood sugar monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Uses of Minglip Bos 2mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Minglip Bos 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take Minglip Bos 2mg/500mg/0.2mg Tablet on an empty stomach.

Common Side effects of Minglip Bos 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Minglip Bos 2mg/500mg/0.2mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Consume the Minglip Bos 2mg/500mg/0.2mg tablet on an empty stomach.

How Minglip Bos 2mg/500mg/0.2mg Tablet works:

The triple-action antidiabetic tablet, Minglip Bos, contains 2mg, 500mg, and 0.2mg of three distinct medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Minglip Bos 2mg/500mg/0.2mg Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Minglip Bos 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Consult your physician for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Minglip Bos 2mg/500mg/0.2mg Tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Minglip Bos 2mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Minglip Bos 2mg/500mg/0.2mg Tablets is discouraged in those with severe kidney impairment.

LiverLiverCAUTION

Exercise caution when administering Minglip Bos 2mg/500mg/0.2mg Tablet to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver dysfunction, initiate treatment with a reduced Minglip Bos 2mg/500mg/0.2mg Tablet dosage; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Minglip Bos 2mg/500mg/0.2mg Tablet :

Should you forget a Minglip Bos 2mg/500mg/0.2mg Tablet dose, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Minglip Bos 2mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Minglip Bos 2mg/500mg/0.2mg Tablet

Minglip Bos 2mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This medication is unsuitable for type 1 diabetes.
Minglip Bos 2mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, taste changes, flatulence, stomach pain, headache, rash, and respiratory infections.
Minglip Bos 2mg/500mg/0.2mg Tablets are contraindicated in patients allergic to any constituent. Avoid use in patients with moderate-to-severe kidney disease, inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Minglip Bos 2mg/500mg/0.2mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Yes, Minglip Bos 2mg/500mg/0.2mg Tablets can lower blood sugar, potentially causing hypoglycemia. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication, tightly sealed, in its original packaging. Follow the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Minglip Bos 2mg/500mg/0.2...
98
MRP 119
17% off